-
Mashup Score: 3Digestive Disease Week - 14 hour(s) ago
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
Source: www.hcplive.comCategories: General Medicine NewsTweet
-
Mashup Score: 3Digestive Disease Week - 20 hour(s) ago
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
Check out what we’ve been up to at #DDW2024 and stay up to date with our latest conference coverage: https://t.co/XlMycxNbpe https://t.co/OGIKjQX5Jp
-
-
Mashup Score: 8Submit an Abstract - 5 month(s) ago
Showcase your novel research and gain valuable feedback from your peers by submitting an abstract for consideration for DDW.
Source: ddw.orgCategories: General Medicine News, GastroenterologyTweet-
Final reminder 💥 #DDW2024 abstract submission closes this Thursday, Nov. 30 at 9 p.m. EST! We know you're working hard and can't wait to see the science that will be a part of AGA education at @DDWMeeting. Look for additional details + resources here ➡️https://t.co/FCCfB3YSL4 https://t.co/WCJnfOcQVx
-
-
Mashup Score: 8Submit an Abstract - 5 month(s) ago
Showcase your novel research and gain valuable feedback from your peers by submitting an abstract for consideration for DDW.
Source: ddw.orgCategories: General Medicine News, GastroenterologyTweet-
Final reminder 💥 #DDW2024 abstract submission closes this Thursday, Nov. 30 at 9 p.m. EST! We know you're working hard and can't wait to see the science that will be a part of AGA education at @DDWMeeting. Look for additional details + resources here ➡️https://t.co/FCCfB3YSL4 https://t.co/WCJnfOcQVx
-
-
Mashup Score: 8Submit an Abstract - 5 month(s) ago
Showcase your novel research and gain valuable feedback from your peers by submitting an abstract for consideration for DDW.
Source: ddw.orgCategories: General Medicine News, GastroenterologyTweet-
Final reminder 💥 #DDW2024 abstract submission closes this Thursday, Nov. 30 at 9 p.m. EST! We know you're working hard and can't wait to see the science that will be a part of AGA education at @DDWMeeting. Look for additional details + resources here ➡️https://t.co/FCCfB3YSL4 https://t.co/WCJnfOcQVx
-
-
Mashup Score: 0Highlights in IBS-C From Digestive Disease Week 2024 – Gastroenterology & Hepatology - 9 month(s) ago
With Expert Comments by: Darren M. Brenner, MD Professor of Medicine (Gastroenterology and Hepatology) and Surgery Northwestern Medicine Northwestern University Feinberg School of Medicine Chicago, Illinois A Review of Selected Posters and CME Symposium From DDW 2024 May 18-21, 2024 • Washington, DC Irritable bowel syndrome (IBS) is commonly accompanied by diarrhea but may instead be marked by constipation (IBS-C).1 IBS-C affects approximately 29% of the population and can cause severe deterioration in
Categories: General Medicine News, GastroenterologyTweet-
“Highlights in IBS-C From Digestive Disease Week 2024” with expert comments by Darren M. Brenner, MD https://t.co/7MinTOubD7 #DDW2024 @DDWMeeting @dbrennerGIMD @NorthwesternMed @NUFeinbergMed
-
-
Mashup Score: 0Highlights in Ulcerative Colitis From Digestive Disease Week 2024 – Gastroenterology & Hepatology - 9 month(s) ago
A Review of Selected Presentations From DDW 2024 May 18-21, 2024 • Washington, DC Mirikizumab is a monoclonal antibody directed against the p19 subunit of interleukin 23 (IL-23) that is approved for the treatment of moderately to severely active ulcerative colitis (UC).1,2 The double-blind phase 3 LUCENT-1 and LUCENT-2 trials evaluated mirikizumab vs placebo as therapy for patients with moderately to severely active UC.3 In the LUCENT-1 trial, 1281 patients were randomized 3:1 to receive mirikizumab (300
Categories: General Medicine News, GastroenterologyTweet-
“Highlights in Ulcerative Colitis From Digestive Disease Week 2024” with expert comments by Gary R. Lichtenstein, MD https://t.co/nQTA4S8cUc #DDW2024 @DDWMeeting
-
-
Mashup Score: 1Highlights in Crohn’s Disease From Digestive Disease Week 2024 – Gastroenterology & Hepatology - 9 month(s) ago
Expert Comments by: Millie D. Long, MD, MPH Professor of Medicine Department of Medicine, Division of Gastroenterology and Hepatology UNC School of Medicine University of North Carolina at Chapel Hill Chapel Hill, North Carolina A Review of Selected Presentations From DDW 2024 May 18-21, 2024 • Washington, DC The oral selective Janus kinase inhibitor upadacitinib received US Food and Drug Administration (FDA) approval for the treatment of adults with moderately to severely active Crohn’s disease (CD) who
Categories: General Medicine News, GastroenterologyTweet-
“Highlights in Crohn’s Disease From Digestive Disease Week 2024” with expert comments by Millie D. Long, MD, MPH https://t.co/XQ4hBM3MxT #DDW2024 @DDWMeeting @mlongmd @uncgastro
-
-
Mashup Score: 0Late-Night Eaters May Have Increased Risk for Colorectal Cancer - 11 month(s) ago
Late eating could disrupt the peripheral circadian rhythm, part of which is found in the GI tract.
Source: www.mdedge.comCategories: General Medicine News, General HCPsTweet-
🍽️ New research from #DDW2024 suggests eating within 3 hours of bedtime at least 4 times a week may raise the risk of colorectal cancer. https://t.co/QCTC6R5ezV https://t.co/WAZzw24ePL
-
-
Mashup Score: 0Alan Bonder, MD: Phase 2 Data for Combination Obeticholic Acid, Bezafibrate in PBC - 11 month(s) ago
Bonder explains key therapeutic targets in primary biliary cholangitis and why combination obeticholic acid and bezafibrate may be a promising option.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Check out this Q&A with @BonderAlan from #DDW2024 about the short-term administration of combination obeticholic acid and bezafibrate in PBC: https://t.co/dezdUSo4yi
-
Check out what we’ve been up to at #DDW2024 and stay up to date with our latest conference coverage: https://t.co/XlMycxNbpe https://t.co/OGIKjQX5Jp